$KOD ~$88 - Has risen from $2 within last few years. This morning jumped UP $55+ / UP 165% upon news of positive data from their phase 3 trials for Zenkuda and

$KOD ~$88 - Has risen from $2 within last few years. This morning jumped UP $55+ / UP 165% upon news of positive data from their phase 3 trials for Zenkuda and tabirafusp-ted that met Primary Endpoints in Pivotal DAYBREAK Trial in wAMD, with Zenkuda Demonstrating a Potential New Standard-of-Care Pro…